The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninova V, Heron-Milhavet L, Robin M, Jeanson L, et al. BMC Cancer 2024;24:587.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slaninova V, Heron-Milhavet L, Robin M, Jeanson L, et al. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. BMC Cancer 2024;24:587.
PMID: 38741073